Cell characterization
Products and assays help investigators assess identity, phenotype, function, purity, and research utility.
Solutions
Therapeutic research solutions • Solution 05
Cell Therapy
Human-derived products, assays, and research support for hematopoietic cellular therapy, immunotherapy, and regenerative medicine.
Scientific objective first
Characterize the cells, understand their interactions, and build more dependable models for advanced therapeutic research.
Cell therapies are at the forefront of research into neurological disorders, cancer, conditions associated with aging, and other complex diseases. LeoCorps produces biospecimens in equipped processing environments using quality-focused research and development practices.
Application-aligned tools
Turnkey reagents and cellular-analysis kits can be aligned with the scientific needs of a project.
Connected handling
Collection, processing, packaging, transport, and testing considerations are coordinated across the workflow.
Research-focused materialsHematopoietic • immune • regenerative
The research context
Designed around demanding scientific work.
The team draws on extensive field experience to support collection, processing, packaging, and transport. Research reagents and in vitro cellular-analysis kits can be designed around project-specific requirements to strengthen in vitro and in vivo investigation.
Explore our standardsCell-therapy research areas
Three connected fields of investigation.
Explore the specialized research context, materials, and analytical priorities for each pathway.
Connected research support
A disciplined path from source to study.
Material sourcing, characterization, quality-focused preparation, and controlled delivery work together to protect research value.
- 01Source
- 02Characterize
- 03Prepare
- 04Deliver
Build around the research need
Define the material, criteria, and workflow.
Share the scientific objective, cell or tissue type, donor requirements, assay needs, processing specifications, documentation, and timeline.